📢 We have a new Science letter! 📢 Ion channels are imperative to the normal functioning of the cell. Find out their key roles and potential as promising targets in pathologies, in this letter by Dr. Christophe Vandier. lifesometherapeutics.com/news #sciencenews

Today is #RareDiseaseDay We stand together in support of rare disease community. Let's raise awareness of rare diseases and the urgent need to accelerate treatment options. Rare is many. Rare is strong. Rare is proud.

Today and every single day, happy International Women's Day. EQUALITY & RESPECT The fight is on and we'll never give up. EVERYDAY IS WOMEN'S DAY. #EachforEqual #Respect #WomensDay2024

We have just inaugurated our #Microbiology Lab! Here, we will investigate the #antibiotic properties of Ohmline, our therapeutic #nanotech system. Let’s fight antibiotic resistance together! #DrugDevelopment #Biotech

Lifesome has been invited by Comunidad de Madrid to visit the #innovation ecosystem of the Greater Boston Area next April 23-26! If you are an investor, a researcher, a company or simply curious about us, let's meet at Harvard University & Venture Café Cambridge! 🧪#biotech #nanotech

Great news for Lifesome Therapeutics's team👏👏👏 ! Hope it'll help you move several steps forward at a time😉

More great April news! We are happy to announce that Dr Luis Tebar has joined our team! Thanks for bringing your expertise in Regulatory Affairs to the company. We are excited to keep working to develop new #antibiotic and #antitumoral drugs together! 🧪🧫 #biotech #nanotech

Lifesome Therapeutics has just come back from Massachussetts, where we were invited to join their #Innovation Ecosystem! It has been a pleasure to visit the Real Colegio Complutense at Harvard, the Massachusetts Institute of Technology (MIT) and many other exciting places, so thank you all for having us there! #biotech #nanotech

Desde Lifesome estamos buscando colaboradores (medianas empresas o grupos públicos de investigación) para presentarnos a la Convocatoria TransMisiones 2024 del CDTI y la AEI. ¿Trabajas en #antibióticos y #bacterias multirresistentes? ¡Trabajemos juntos en la propuesta!

We are glad to share our latest publication at Journal of Colloid and Interface #Science (IF: 9.9), where we describe in-depth the unique characteristics of the #nanotubes formed from Ohmline. Let's check it here! sciencedirect.com/science/articl…

Lifesome has become an official member of AseBio - Asociación Española de Bioempresas! Read their interview with Diego (our #Cancer & #Microbiology Research Scientist) here!

Great news from our #Oncology R&D team: Lifesome has just been announced as a beneficiary in the 2024 DeepTech Madrid call from Madri+d! #biotech #nanotech #healthcare #science

September arrives with important news at Lifesome: Alberto Encinas has officially joined us as a Research Scientist! Welcome to the team, Alberto! Also, we have a new website that we would like you to see and share: lifesometherapeutics.com! Stay connected for more news! #nanotech

#Research means more life and we are committed to it! Learn all about Lifesome's #cancer projects here: linkedin.com/posts/lifesome… #WorldCancerResearchDay #TodosContraelCáncer #biotech #nanotech Asociación Española Contra el Cáncer

If you are attending the Festival of Biologics in Basel next week (October 15-17), please do not hesitate to visit our booth at S53! Together, we can establish new synergies to fight #cancer and #AntimicrobialResistance

Could you imagine looking for #lipids useful to treat #cancer in marine products? Christophe Vandier, our co-founder and CTO, has talked about it in this exciting new article! Let us know your impressions about it! #biotech #science theconversation.com/sardines-maque…

This week has been declared as the World #AntimicrobialResistance (AMR) Awareness Week 🦠 In Lifesome, we tackle AMR through different projects included in our #Microbiology pipeline 🧫 Check some of the activities that we perform at FPCM here: linkedin.com/feed/update/ur…

Our project nanoBACTair has been selected as one of the beneficiaries of @CDTI_innovacion MultiPais 2024 Call! Thanks to this, we will study the antimicrobial role of Ohmline, our lipidic nanovector, at our lab in FPCM #science #microbiology linkedin.com/posts/lifesome…

In today’s #WorldCancerDay, we would like to highlight new projects that we are performing to study both the #antitumoral and #neuroprotective effects of Ohmline, our proprietary synthetic glycolipid #science #research

On this International Day of Women and Girls in #Science, we would like to highlight the importance of promoting equal career opportunities and diversity in our workspaces. Together we are stronger!